By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Lexicon Pharma (LXRX) Release: European Commission (EC) Approves XERMELO (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy 9/20/2017 8:38:57 AM
Ipsen (IPN.PA) Receives Approval From European Commission (EC) For Xermelo (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Patients Inadequately Controlled By Somatostatin Analogue Therapy 9/19/2017 10:57:13 AM
European Commission (EC) Approves Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer 9/5/2017 8:43:17 AM
Amgen (AMGN) Release: European Commission (EC) Approves Expanded Use Of Mimpara (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis 9/1/2017 6:18:52 AM
Minerva Neurosciences (NERV) Announces European Commission (EC) Approval Of Amendment Of MIN-202 Agreement With Janssen Pharmaceutica N.V. 8/25/2017 8:18:34 AM
Samsung Bioepis First To Obtain European Commission (EC) Approval For A Third Anti-TNF-? Biosimilar With Imraldi (Adalimumab) 8/25/2017 7:43:51 AM
The European Commission (EC) Finally Approves Merck KGaA (MKGAF.PK)'s Once-Failed MS Drug Cladribine 8/25/2017 6:54:38 AM
Alexion (ALXN) Release: European Commission (EC) Grants New Indication For Soliris (Eculizumab) For The Treatment Of Patients With Refractory Generalized Myasthenia Gravis (gMG) 8/21/2017 8:06:52 AM
European Commission (EC) Grants AbbVie (ABBV)'s MAVIRET (Glecaprevir/Pibrentasvir) Marketing Authorization For The Treatment Of Chronic Hepatitis C In All Major Genotypes (GT1-6) 7/28/2017 9:14:57 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) For The Treatment Of All Genotypes Of Chronic Hepatitis C 7/28/2017 6:11:41 AM
12345678910...
//-->